Symptom Burden Guiding Invasive Electrophysiological Study in Paroxysmal Supraventricular Tachycardia (BELIEVE-SVT)

Madrid Health Service

Status: Completed

Conditions: Supraventricular Tachycardia

Treatments: Procedure: Electrophysiological study (and ablation when appropriate)

Study type: Observational

Funder types: Other

Identifiers

NCT06046352

19/562

Details and patient eligibility

About

BELIEVE-SVT is a European multi-centre, retrospective registry in tertiary hospitals performing electrophysiological study in patients with palpitations considered clinically suggestive of paroxysmal supraventricular tachycardia by a cardiologist and without electrocardiographic documentation of tachycardia or preexcitation. Clinical characteristics, results of electrophysiological study and ablation, complications, and clinical outcomes during follow-up will be analysed.

Full description

The "Symptom Burden As Guiding Principle For Invasive Electrophysiological Study In Paroxysmal Supraventricular Tachycardia (Believe-SVT)" study was a multi-centre, retrospective, observational registry carried out in tertiary European hospitals. Inclusion criteria were: symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist; absence of any sort of electrocardiographic tracing during episodes (including wearables and other single lead devices), and having undergone an electrophysiological study aimed at the diagnosis of paroxysmal supraventricular tachycardia.

Enrollment: 711 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Symptoms that were considered suggestive of paroxysmal supraventricular tachycardia by a cardiologist and/or cardiac electrophysiologist
• Absence of any sort of ECG tracing during episodes (including wearables and other single lead devices)

Exclusion criteria

• Documentation of preexcitation
• Prior electrophysiological study aimed at the assessment of ventriculo-atrial conduction or induction of supraventricular tachycardias.

Trial design

711 participants in 1 patient group

Cohort

Description:

Non-documented, clinically-suspected PSVT

Treatment:

Procedure: Electrophysiological study (and ablation when appropriate)